Phibro Animal Health LimitedThursday, 19 July 2018
ByrneWallace advised Phibro Animal Health Corporation ("PAHC"), a NASDAQ listed global diverse animal health and mineral nutrition company, in relation to the establishment in Ireland of its Irish subsidiary, Phibro Animal Health Limited ("Phibro Ireland").
ByrneWallace also advised PAHC and Phibro Ireland in relation to the acquisition of an animal health facility in Sligo from Elanco. Phibro Ireland plans to develop what is Phibro’s first biologicals manufacturing location in Europe to produce a range of innovative animal health vaccines, creating up to 150 jobs over 5 years.
The ByrneWallace team who advised on the transaction comprised of Colin Sainsbury, Partner and Head of Life Sciences, Michael Walsh, Partner and Head of Property, Martin Cooney, Partner and Head of Construction, Anthony Smyth, Head of Tax and Michelle McVeigh, Senior Associate, Property.